KRAS and cancer: KRAS G12R mutations are highly unique for pancreas cancer as they are exceedingly rare, or non-existent, in other cancers (1% in thyroid cancers, <2% in NSCLC, <2% in colon cancers of all KRAS mutant cancers) [17].